STOCK TITAN

Veralto CEO Honeycutt sells 7,098 shares at $105

The exercised options were fully vested, and the reported derivative position was 0 options following the transaction.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

On October 23, 2026, Veralto Corp (VLTO) President and CEO Jennifer Honeycutt exercised fully vested options covering 7,098 common shares at an exercise price of $28.76 per share and sold 7,098 common shares at $105.00 per share. Both transactions were made under a Rule 10b5-1 trading plan adopted February 25, 2026.

Insider Honeycutt Jennifer
Role President and CEO
Sold 7,098 shs ($745K)
Approx. gross sale proceeds $745K
Approx. exercise cost $204K
Approx. pre-tax spread $541K
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) F1, F2 7,098 $0.00 $0.00
Exercise Common Stock F1 7,098 $28.76 $204K
Sale Common Stock F1 7,098 $105.00 $745K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 120,060 shares (Direct)
Footnotes (2)
  1. F1. This report transaction was effectuated pursuant to a previously disclosed Rule 10b5-1 trading plan adopted by the person on February 25, 2026.
  2. F2. Represents stock options that are fully vested.
Options exercised 7,098 options October 23, 2026
Exercise price $28.76 per share Options exercised October 23, 2026
Common shares sold 7,098 shares October 23, 2026
Sale price $105.00 per share Sale on October 23, 2026
Derivative position following transaction 0 options Reported after the October 23, 2026 transaction
Rule 10b5-1 trading plan regulatory
"pursuant to a previously disclosed Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
fully vested financial
"stock options that are fully vested"
Employee Stock Option (Right to Buy) technical
"Employee Stock Option (Right to Buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did Veralto CEO Jennifer Honeycutt sell?

Jennifer Honeycutt sold 7,098 common shares at $105.00 per share on October 23, 2026. The transaction was made under a Rule 10b5-1 trading plan adopted February 25, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Honeycutt Jennifer

(Last)(First)(Middle)
C/O VERALTO CORPORATION
225 WYMAN STREET, SUITE 250

(Street)
WALTHAM MASSACHUSETTS 02451

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Veralto Corp [ VLTO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/23/2026M7,098(1)A$28.76127,158D
Common Stock10/23/2026S7,098(1)D$105120,060D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$28.7610/23/2026M7,098(1) (2)02/24/2027Common Stock7,098$00D
Explanation of Responses:
1. This report transaction was effectuated pursuant to a previously disclosed Rule 10b5-1 trading plan adopted by the person on February 25, 2026.
2. Represents stock options that are fully vested.
Remarks:
/s/ James Tanaka, as attorney-in-fact10/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading